Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 26Prostatic Neoplasms 5Stomach Neoplasms 3Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Rectal Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms, Male 2Adenocarcinoma Of Esophagus 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cyclophosphamide 11Vincristine 9Temozolomide 7Magnetic Resonance Spectroscopy 6Irinotecan 6Filgrastim 6Etoposide 6Doxorubicin 6X-Rays 5Phantoms, Imaging 5Ifosfamide 5Dactinomycin 5cixutumumab 4Vinorelbine 4Specimen Handling 4Sirolimus 4Nuclear Medicine Department, Hospital 4Melphalan 4Gemcitabine 4pegfilgrastim 3palbociclib 3Tacrolimus 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Dexrazoxane 3Biopsy 3ulixertinib 2tipifarnib 2thymoglobulin 2temsirolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Rhabdomyosarcoma × ixabepilone × Clear all
NCT00331643 2014-11-14

Ixabepilone in Treating Young Patients With Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 2 Completed
120 enrolled
CNSGenitourinarySarcoma

Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Sarcoma, Synovial, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡